Myositis and myasthenia during nivolumab administration for advanced lung cancer: a case report and review of the literature

被引:11
|
作者
Veccia, Antonello [1 ]
Kinspergher, Stefania [1 ]
Grego, Elisabetta [1 ]
Peterlana, Dimitri [2 ]
Berti, Alvise [3 ]
Tranquillini, Enzo
Caffo, Orazio [1 ]
机构
[1] Santa Chiara Hosp, Med Oncol, Largo Medaglie Oro 1, I-38122 Trento, Italy
[2] Santa Chiara Hosp, Internal Med, Trento, Italy
[3] Santa Chiara Hosp, Neurol, Trento, Italy
关键词
lung cancer; myasthenia; myositis; nivolumab; CELL; DOCETAXEL; COMPLICATIONS; GRAVIS;
D O I
10.1097/CAD.0000000000000903
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The immunotherapy significantly improved survival of non-small cell lung cancer patients, but it may cause immune-related adverse events, which are severe in less than 10% of cases. We report the case of one patient who developed myositis and myasthenia during nivolumab treatment for metastatic lung squamous carcinoma. Moreover, we reviewed literature data in order to identify similar cases in cancer patients treated with immune-checkpoints inhibitors. A 65-year-old patient, who had previously received a first-line platinum-based therapy, developed diplopia and ptosis 4 weeks after the start of nivolumab. Although antibodies associated with myositis, myasthenia gravis and paraneoplastic syndromes were absent, immune-related myositis and myasthenia were diagnosed. Corticosteroids, immunoglobulin and pyridostigmine showed poor efficacy and the patient died 7 weeks after the appearance of the first symptoms. Fifteen similar cases were found in the literature. A close collaboration between different specialists is essential to rapidly identify and treat severe immune-related adverse events.
引用
收藏
页码:540 / 544
页数:5
相关论文
共 50 条
  • [1] Nivolumab-induced myositis: A case report and a literature review
    Bourgeois-Vionnet, Julie
    Joubert, Bastien
    Bernard, Emilien
    Sia, Marie Angele
    Pante, Vanessa
    Fabien, Nicole
    Honnorat, Jerome
    Streichenberger, Nathalie
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2018, 387 : 51 - 53
  • [2] Myasthenia gravis induced by nivolumab in patients with non-small-cell lung cancer: a case report and literature review
    Hasegawa, Yoshikazu
    Kawai, Shigeru
    Ota, Takayo
    Tsukuda, Hiroshi
    Fukuoka, Masahiro
    IMMUNOTHERAPY, 2017, 9 (09) : 701 - 707
  • [3] Coexisting myasthenia gravis, myositis, and polyneuropathy induced by ipilimumab and nivolumab in a patient with non-small-cell lung cancer A case report and literature review
    Chen, Jia-Hung
    Lee, Kang-Yun
    Hu, Chaur-Jong
    Chung, Chen-Chih
    MEDICINE, 2017, 96 (50)
  • [4] Bullous Lupus Under Nivolumab Treatment for Lung Cancer: A Case Report With Systematic Literature Review
    Wouters, Alicia
    Durieux, Valerie
    Kolivras, Athanassios
    Meert, Anne-Pascale
    Sculier, Jean-Paul
    ANTICANCER RESEARCH, 2019, 39 (06) : 3003 - 3008
  • [5] Camrelizumab-Related Myocarditis and Myositis With Myasthenia Gravis: A Case Report and Literature Review
    Bai, Jing
    Li, Dan
    Yang, Peidan
    Xu, Kunyan
    Wang, Yingnan
    Li, Qian
    Liu, Jiang
    Du, Wenli
    Zhang, Fengbin
    Feng, Rui
    FRONTIERS IN ONCOLOGY, 2022, 11
  • [6] Pyodermitis during Nivolumab Treatment for Non-Small Cell Lung Cancer: A Case Report and Review of the Literature
    Cosio, Terenzio
    Coniglione, Filadelfo
    Flaminio, Valeria
    Gaziano, Roberta
    Coletta, Deborah
    Petruccelli, Rosalba
    Dika, Emi
    Bianchi, Luca
    Campione, Elena
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (05)
  • [7] Management of cardiac tamponade during nivolumab of lung cancer with intrapericardial bleomycin: case report
    Asai, Maiko
    Kato, Yasuhiro
    Kawai, Shoko
    Watanabe, Kageaki
    Yomota, Makiko
    Okuma, Yusuke
    Hosomi, Yukio
    Hishima, Tsunekazu
    Okamura, Tatsuru
    IMMUNOTHERAPY, 2019, 11 (06) : 467 - 472
  • [8] Psoriatic arthritis due to nivolumab administration a case report and review of the literature
    Sapalidis, Konstantinos
    Kosmidis, Christoforos
    Michalopoulos, Nikolaos
    Koulouris, Charilaos
    Mantalobas, Stylianos
    Giannakidis, Dimitrios
    Munteanu, Alexandru
    Surlin, Valeriu
    Laskou, Stella
    Zarogoulidis, Paul
    Drougas, Dimitrios
    Sardeli, Crysanthi
    Karapantzou, Chrysanthi
    Karapantzos, Ilias
    Hohenforst-Schmidt, Wolfgang
    Huang, Haidong
    Kesisoglou, Isaak
    RESPIRATORY MEDICINE CASE REPORTS, 2018, 23 : 182 - 187
  • [9] Locally advanced rectal cancer receiving total neoadjuvant therapy combined with nivolumab: a case report and literature review
    Mori, Ryota
    Uemura, Mamoru
    Sekido, Yuki
    Hata, Tsuyoshi
    Ogino, Takayuki
    Takahashi, Hidekazu
    Miyoshi, Norikatsu
    Mizushima, Tsunekazu
    Doki, Yuichiro
    Eguchi, Hidetoshi
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2022, 20 (01)
  • [10] Autoimmune-related encephalitis during treatment with nivolumab for advanced head and neck cancer: a case report and literature review
    Guidi, Alessandro
    Violati, Martina
    Blasi, Miriam
    Ferrari, Elettra
    Luciani, Andrea
    Codeca, Carla
    Ferrari, Daris
    TUMORI JOURNAL, 2020, 106 (06): : NP23 - NP28